Peptides Rapidly Transport Antibiotic Across the Intact Tympanic Membrane to Treat a Middle Ear Infection
Authors:
Preprint
- 3 August 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
The tympanic membrane (TM) forms an impermeable barrier to medical therapies for middle ear (ME) diseases like otitis media. By screening a phage-displayed peptide library, we have previously discovered rare peptides that mediate active transport of cargo across the intact membrane of animals and humans. Since the M13 filamentous bacteriophage on which the peptides are expressed are large (nearly 1 µm in length), this offers the possibility of noninvasively delivering drugs, large drug packages or gene therapy to the ME. To evaluate this possibility, EDC chemistry was employed to covalently attach amoxicillin or neomycin molecules to phage bearing a trans-TM peptide, as a model for large drug packages. Eight hours after application of antibiotic-phage to the TM of infected rats, ME bacterial titers were substantially reduced compared to untreated animals. As a control, antibiotic was linked to wild-type phage, not bearing any peptide, and application to the TM did not affect ME bacteria. The results support the ability of rare peptides to actively deliver pharmacologically relevant amounts of drugs through the intact TM and into the ME. Moreover, since bacteriophage engineered to express peptides are viral vectors, the trans-TM peptides could also transport other viral vectors into the ME.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Phage treatment of human infectionsBacteriophage, 2011
- Otitis media across nine countries: Disease burden and managementInternational Journal of Pediatric Otorhinolaryngology, 2010
- Multiple facets of intestinal permeability and epithelial handling of dietary antigensMucosal Immunology, 2010
- A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacyClinical Otolaryngology, 2009
- Targeted Drug-Carrying Bacteriophages as Antibacterial NanomedicinesAntimicrobial Agents and Chemotherapy, 2007
- Mechanisms and Management of Antibiotic‐Associated DiarrheaClinical Infectious Diseases, 1998
- Epidemiology of Otitis Media During the First Seven Years of Life in Children in Greater Boston: A Prospective, Cohort StudyThe Journal of Infectious Diseases, 1989
- Late Results of Treatment with Ventilation Tubes for Secretory Otitis Media in ENT PracticeActa Oto-Laryngologica, 1989
- Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion SurfaceScience, 1985
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983